Related Research Articles
Biotechnology is the integration of natural sciences and engineering sciences in order to achieve the application of organisms, cells, parts thereof and molecular analogues for products and services. The term biotechnology was first used by Károly Ereky in 1919, meaning the production of products from raw materials with the aid of living organisms.
Brook Byers is a senior partner at Kleiner Perkins Caufield & Byers and the brother of Stanford University Professor Tom Byers and Atlanta, Georgia engineering entrepreneur Ken Byers.
Biocon Limited is an Indian biopharmaceutical company based in Bangalore. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Guanzhou Island, formerly known in English as Dove Island, is an island in Haizhu District, Guangzhou, Guangdong Province, China. It is also branded as Guangzhou International Biotech Island since July 2011, forming the centre of Guangzhou's biotech basis.
The pharmaceutical industry is one of the leading industries in the People's Republic of China, covering synthetic chemicals and drugs, prepared Chinese medicines, medical devices, apparatus and instruments, hygiene materials, packing materials, and pharmaceutical machinery. China has the second-largest pharmaceutical market in the world as of 2017 which is worth US$110 billion. China accounts for 20% of the world's population but only a small fraction of the global drug market. China's changing health-care environment is designed to extend basic health insurance to a larger portion of the population and give individuals greater access to products and services. Following the period of change, the pharmaceutical industry is expected to continue its expansion.
The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 50% of all vaccines manufactured in the world. With industry standards compliant mega production capabilities and large number of skilled domestic workforce, Indian exports meet the standards and requirements of highly regulated markets of USA, UK, European Union and Canada. According to the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, domestic pharmaceutical market turnover reached Rs 129,015 crore in 2018, growing 9.4 per cent year-on-year and exports revenue was US$17.28 billion in FY18 and US$19.14 billion in FY19.
Genome Valley is an Indian high-technology business district spread across 2,000-acre (8.1 km2)/(3.1 sq mi) in Hyderabad, India. It is located across the suburbs, Turakapally, Shamirpet, Medchal, Uppal, Patancheru, Jeedimetla, Gachibowli and Keesara. The Genome Valley has developed as a cluster for Biomedical research, training and manufacturing. Genome Valley is now into its Phase III, which is about 11 kms from the Phase I and II with the total area approximately 2,000-acre (8.1 km2).
The Michigan Life Sciences Corridor (MLSC) is a $1 billion biotechnology initiative in the U.S. state of Michigan.
Sartorius AG is an international pharmaceutical and laboratory equipment supplier, covering the segments of Bioprocess Solutions and Lab Products & Services.
UF Innovate | Accelerate @ Sid Martin Biotech is located in Alachua, Florida, in Progress District. The program's mission is to foster the growth of bioscience startup companies that have some relationship to the university. The Incubator works with companies in all product areas relating to the life sciences, biomedical research, medicine, and chemical sciences.
Ivor Royston, M.D., is an oncologist, researcher, scientist, entrepreneur and venture capitalist, recognized for his efforts to develop treatments for multiple disease targets and to fund biotechnology companies with promising science, technology or medicines. He speaks regularly at healthcare conferences and symposia throughout the United States, Europe and Asia.
China has seen double-digit growth in its biotechnology industry and has gone from being one of the slowest to one of the fastest nations in the adoption of new biotechnologies. The biotech sector is seen in China and internationally as a core area of national scientific and economic development. The main national biotech body in the country is the China National Center for Biotechnology Development. The CNCBD is an organization established on November 3, 1983, under the Ministry of Science and Technology with the approval of the State Council. CNCBD is the sole national center to coordinate and implement the national S&T program in Biotechnology and Health.
The Ohio bioscience sector strength was ranked #4 among USA states in 2008 by Business Facilities magazine.
Maharaj Kishan Bhan was an Indian pediatrician and clinical scientist. He received M.B.B.S. Degree (1969) from Armed Forces Medical College, Pune and M.D. Degree from Post Graduate Institute of Medical Education and Research, Chandigarh. He carried out extensive post doctoral research at All India Institute of Medical Sciences in the areas of diarrheal diseases and child nutrition with an emphasis on public health issues. He served as the president of the Jawaharlal Nehru Institute of Postgraduate Medical Education & Research (JIPMER).
Arie S. Belldegrun, FACS, is an Israeli-American urologic oncologist, billionaire businessman and investor.
Henri A. Termeer was a Dutch biotechnology executive and entrepreneur who is considered a pioneer in corporate strategy in the biotechnology industry for his tenure as CEO at Genzyme. Termeer created a business model adopted by many others in the biotech industry by garnering steep prices— mainly from insurers and government payers— for therapies for rare genetic disorders known as orphan diseases that mainly affect children. Genzyme uses biological processes to manufacture drugs that are not easily copied by generic-drug makers. The drugs are also protected by orphan drug acts in various countries which provides extensive protection from competition and ensures coverage by publicly funded insurers. As CEO of Genzyme from 1981 to 2011, he developed corporate strategies for growth including optimizing institutional embeddedness nurturing vast networks of influential groups and clusters: doctors, private equity, patient-groups, insurance, healthcare umbrella organizations, state and local government, and alumni. Termeer was "connected to 311 board members in 17 different organizations across 20 different industries" He has the legacy of being the "longest-serving CEO in the biotechnology industry.
The Biotechnology Innovation Organization (BIO) is the largest advocacy association in the world representing the biotechnology industry.
Shenzhen International BT Leadership Summit is a biology-focused business conference. It is held each year in September. It is arranged by the Shenzhen Municipal People's Government. It is held at the Shenzhen Convention and Exhibition Center.
Avantor, Inc. is a chemicals and materials company headquartered in Radnor, Pennsylvania. The company ranked 484th on the 2020 Fortune 500, based on its 2019 sales.
GenScript Biotech Corporation is a global biotechnology group, founded in New Jersey, United States in 2002, by Dr. Fangliang (Frank) Zhang, and listed on the Hong Kong Stock Exchange in 2015. Currently, the rotating CEO of GenScript is Dr. Zhenyu Liu., GenScript operates in over 100 countries and regions worldwide, with legal entities located in the US, China, Hong Kong, Japan, Singapore, the Netherlands, and Ireland. GenScript provides products and services to over 100,000 customers.,
References
- ↑ China Carves Niche in Pharma Outsourcing
- ↑ who we are Archived 2012-07-10 at archive.today
- ↑ Healthcare Committee - American Chamber of Commerce in Shanghai
- ↑ BioMedical Asia 2009 - Mr Matthew Chervenak
- ↑ BioPartnering China™ Archived 2011-07-16 at the Wayback Machine
- ↑ Drug Discovery Today
- ↑ An Emerging Biotech Giant? - CBR May-June 2005 Archived 2008-10-23 at the Wayback Machine
- ↑ Box 1: E&Y report backs Asia-Pacific biotech: Nature Biotechnology